Unlock instant, AI-driven research and patent intelligence for your innovation.
Drug combination for treatment of cerebrovascular diseases and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for cerebrovascular disease and composition, applied in the field of medicine, can solve the problem of not being able to treat both the symptoms and root causes, and achieve the effect of preventing pain
Inactive Publication Date: 2017-11-10
李金华
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0002] Some existing medicines and methods for treating cerebral infarction, cerebral hemorrhage and other cerebrovascular diseases, as well as preventing comorbidity or sequelae, apoplexy, etc. due to the above-mentioned cerebrovascular diseases, all have deficiencies and cannot achieve the effect of treating both symptoms and root causes.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0026] The present invention also provides a preparation method of the above-mentioned pharmaceutical composition. The first raw material drug is mixed, pulverized, mixed with water and decocted for at least 20 minutes to obtain a filtrate.
[0027] When the above pharmaceutical composition contains the second raw material, the first raw material and the second raw material are mixed according to parts by weight, pulverized, mixed with water and decocted for at least 20 minutes to obtain a filtrate.
[0028] Wherein, it is preferable to pass through a 20-mesh sieve after the above pulverization, and then decoct the under-sieve for at least 20 minutes, such as 30 minutes, 50 minutes, 60 minutes, etc., to obtain a filtrate.
[0029] Preferably, the undersieve is mixed with water, soaked for 20-40 minutes, and then decocted, so as to save subsequent decoction time. Wherein, decoction can be carried out once, also can carry out step by step, for example, decoct for the first time,...
Embodiment 1
[0032] A pharmaceutical composition for treating cerebrovascular diseases, which is prepared by the following method:
[0033] The first raw drug is mixed, pulverized, mixed with water and decocted for 40 minutes to obtain a filtrate.
[0034] Wherein, the first raw material medicine includes: 15 parts by weight of sumac; 15 parts by weight of salvia miltiorrhiza; 6 parts by weight of leech; 10 parts by weight of earthworm;
Embodiment 2
[0036] A pharmaceutical composition for treating cerebrovascular diseases, which is prepared by the following method:
[0037] The first raw drug is mixed, pulverized, mixed with water and decocted for 20 minutes to obtain a filtrate.
[0038] Wherein, the first raw material medicine includes: 14 parts by weight of sumac; 16 parts by weight of salvia miltiorrhiza; 6 parts by weight of leech; 9 parts by weight of earthworm; 5 parts by weight of astragalus;
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a drug combination for treatment of cerebrovascular diseases and a preparation method thereof, and relates to the field of medicine. The drug combination comprises first crude drugs. The first crude drugs comprise, by weight, 14-16 parts of sappanwood, 14-16 parts of the root of red-rooted salvia, 4-6 parts of hirudo, 9-12 parts of lumbricus and 6-9 parts of stir-baked squama manitis. The brain diseases like cerebral infarction and cerebral hemorrhage can be effectively treated or prevented, and the complications or sequelae caused by the diseases are prevented. The preparation method of the drug combination includes the steps that the first crude drugs are mixed and smashed by weight and then are mixed with water to be decocted for at least 20 minutes, and filter liquor is obtained. The method is simple and controllable, convenient to operate and capable of achieving mass production.
Description
technical field [0001] The invention relates to the field of medicine, and in particular to a pharmaceutical composition for treating cerebrovascular diseases and a preparation method thereof. Background technique [0002] Some existing cerebrovascular diseases such as the treatment of cerebral infarction and cerebral hemorrhage, as well as the medicines and methods for preventing comorbidities or sequelae, apoplexy, etc. due to the above-mentioned cerebrovascular diseases, all have deficiencies and cannot achieve the effect of treating both symptoms and root causes. Contents of the invention [0003] The purpose of the present invention is to provide a pharmaceutical composition for the treatment of cerebrovascular diseases, which has the effects of nourishing qi and activating blood circulation, removing blood stasis and dredging collaterals, promoting blood circulation and resolving phlegm, dispelling wind and reducing blood lipids, etc., and can effectively treat or pre...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
